Pilot study shows the challenges and achievements of conducting a clinical trial of mistletoe therapy for breast cancer patients in the UK
A pilot randomised controlled clinical trial of mistletoe therapy for breast cancer patients has shown that it is feasible to conduct a UK NHS trial. The Mistletoe and Breast Cancer (MAB) Study was led by researchers Professor Gene Feder and Dr Alyson Huntley from the Centre for Academic Primary Care, University of Bristol with NHS partners. A paper published in the journal Cancers describes the trial challenges and achievements.